<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34800846</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0070</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Diagnostic microbiology and infectious disease</Title><ISOAbbreviation>Diagn Microbiol Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Frequency of respiratory pathogens other than SARS-CoV-2 detected during COVID-19 testing.</ArticleTitle><Pagination><StartPage>115576</StartPage><MedlinePgn>115576</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diagmicrobio.2021.115576</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0732-8893(21)00268-6</ELocationID><Abstract><AbstractText>The frequencies of 19 respiratory pathogens other than SARS-CoV-2 were assessed in 6,"?&gt;235 Brazilian individuals tested for COVID-19. Overall, only 83 individuals who tested positive for SARS-CoV-2 had codetection of other pathogens. Individuals infected with Rhinovirus/Enterovirus, Human Coronavirus (HCoV)-HKU1, HCoV-NL63, HPIV-4, Influenza A (-H1N1 and other subtypes), Influenza B, Human Respiratory Syncytial Virus and Human Metapneumovirus were less likely to test positive for SARS-CoV-2. Infection with Streptococcys pyogenes, Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Bordetella pertussis were more frequent in individuals who tested negative for SARS-CoV-2, but without significancy. We found 150 individuals infected with ≥2 pathogens other than SARS-CoV-2, only 3 out of whom tested positive for COVID-19. The codetection frequency was low in individuals diagnosed with COVID-19. Other viral infections may provide a cross-reactive, protective immune response against SARS-CoV-2. Screening for bacterial respiratory infections upon COVID-19 testing is important to drive suitable therapeutic approaches and avoid unnecessary antibiotic prescription.</AbstractText><CopyrightInformation>Copyright © 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boschiero</LastName><ForeName>Matheus Negri</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil; Laboratory of Human and Medical Genetics, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Aires</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>BioISI - Biosystems &amp; Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palamim</LastName><ForeName>Camila Vantini Capasso</ForeName><Initials>CVC</Initials><AffiliationInfo><Affiliation>Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil; Laboratory of Human and Medical Genetics, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Alfonso Eduardo</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Pulmonology and Allergy Pediatric Center, Campinas, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauch</LastName><ForeName>Renan Marrichi</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Center for Investigation in Pediatrics, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marson</LastName><ForeName>Fernando Augusto Lima</ForeName><Initials>FAL</Initials><AffiliationInfo><Affiliation>Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil; Laboratory of Human and Medical Genetics, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil. Electronic address: fernando.marson@usf.edu.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diagn Microbiol Infect Dis</MedlineTA><NlmUniqueID>8305899</NlmUniqueID><ISSNLinking>0732-8893</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="Y">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Codetection</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors report no conflicts of interest relevant to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34800846</ArticleId><ArticleId IdType="pmc">PMC8531239</ArticleId><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115576</ArticleId><ArticleId IdType="pii">S0732-8893(21)00268-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdella R, Aggarwal M, Okura T, Lamb RA, He Y. Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation. Proc Natl Acad Sci U S A. 2020;117:4931–4941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060699</ArticleId><ArticleId IdType="pubmed">32075920</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragon TJ, Fay MP, Wollschlaeger D, Omidpanah A. epitools: epidemiology Tools. (2020).</Citation></Reference><Reference><Citation>Aran D, Beachler DC, Lanes S, Overhage JM. Prior presumed coronavirus infection reduces COVID-19 risk: a cohort study. J Infect. 2020;81:923–930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7590640</ArticleId><ArticleId IdType="pubmed">33127456</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthold MR, Cebron N, Dill F, Gabriel TR, Kotter T, Meinl T, et al. In: Data analysis, machine learning and applications. Preisach C, Burkhardt H, Schmidt-Thieme L, Decker R, editors. Springer; 2008. KNIME: The Konstanz Information Miner; pp. 319–326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-78246-9_38</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishburg E, Okoh A, Nagarakanti SR, Lindner M, Migliore C, Patel P. Fungemia in COVID-19 ICU patients, a single medical center experience. J Med Virol. 2021;93:2810–2814.</Citation><ArticleIdList><ArticleId IdType="pubmed">33107617</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcagno A, Ghisetti V, Burdino E, Trunfio M, Allice T, Boglione L, et al. Co-infection with other respiratory pathogens in COVID-19 patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27:297–298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434691</ArticleId><ArticleId IdType="pubmed">32822882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104:7777–7785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417782</ArticleId><ArticleId IdType="pubmed">32780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7475952</ArticleId><ArticleId IdType="pubmed">32894364</ArticleId></ArticleIdList></Reference><Reference><Citation>CSV Writer. KNIME Hub. 2021. Available at: https://hub.knime.com/knime/extensions/org.knime.features.base/latest/org.knime.base.node.io.filehandling.csv.writer.CSVWriter2NodeFactory. Accessed October 7, 2021.</Citation></Reference><Reference><Citation>Hashemi SA, Safamanesh S, Ghafouri M, Taghavi MR, Mohajer Zadeh Heydari MS, Namdar Ahmadabad H, et al. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran. J Med Virol. 2020;92:2319–2321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272908</ArticleId><ArticleId IdType="pubmed">32410338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazra A, Collison M, Pisano J, Kumar M, Oehler C, Ridgway JP. Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect Control Hosp Epidemiol. 2020;41:1228–1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360954</ArticleId><ArticleId IdType="pubmed">32616098</ArticleId></ArticleIdList></Reference><Reference><Citation>Joiner (deprecated). KNIME Hub. 2021. Available at: https://hub.knime.com/knime/extensions/org.knime.features.base/latest/org.knime.base.node.preproc.joiner.Joiner2NodeFactory. Accessed October 7, 2021.</Citation></Reference><Reference><Citation>Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085–2086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520–521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622–1629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Tao Z-W, Wang L, Yuan M-L, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl) 2020;133:1032–1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147279</ArticleId><ArticleId IdType="pubmed">32118640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Lai X, Chen Z, Tu S, Qin K. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis. 2020;96:683–687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250072</ArticleId><ArticleId IdType="pubmed">32470606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Wang W, Le Grange JM, Wang X, Du S, Li C, et al. Coinfection of SARS-CoV-2 and other respiratory pathogens. Infect Drug Resist. 2020;13:3045–3053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7457866</ArticleId><ArticleId IdType="pubmed">32922049</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Theodoridou K, Poland G. Influenza immunization and COVID-19. Vaccine. 2020;38:6078–6079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388780</ArticleId><ArticleId IdType="pubmed">32773245</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020;76:97–99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177074</ArticleId><ArticleId IdType="pubmed">32345526</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos A da R, Motta FC, Caetano BC, Ogrzewalska M, Garcia CC, Lopes JCO, et al. Identification of SARS-CoV-2 and additional respiratory pathogens cases under the investigation of COVID-19 initial phase in a Brazilian reference laboratory. Mem Inst Oswaldo Cruz. 2020;115</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508282</ArticleId><ArticleId IdType="pubmed">32965332</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello LE, Suman A, Medeiros CB, Prado CA, Rizzatti EG, Nunes FLS, et al. Opening Brazilian COVID-19 patient data to support world research on pandemics. 2020 Jul 30; Available at: https://zenodo.org/record/3966427. Accessed October 7, 2021.</Citation></Reference><Reference><Citation>Ng KW, Faulkner N, Cornish GH, Rosa A, Harvey R, Hussain S, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339–1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Coinfection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus? J Med Virol. 2020;92:1699–1700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267652</ArticleId><ArticleId IdType="pubmed">32352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L, et al. Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial. JAMA. 2021 Ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285753</ArticleId><ArticleId IdType="pubmed">34269813</ArticleId></ArticleIdList></Reference><Reference><Citation>Pongpirul WA, Mott JA, Woodring JV, Uyeki TM, MacArthur JR, Vachiraphan A, et al. Clinical characteristics of patients hospitalized with coronavirus disease, Thailand. Emerg Infect Dis. 2020;26:1580–1585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323520</ArticleId><ArticleId IdType="pubmed">32267826</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475–482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426219</ArticleId><ArticleId IdType="pubmed">32798514</ArticleId></ArticleIdList></Reference><Reference><Citation>PRINCIPLE Trial Collaborative Group Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Lond Engl. 2021;397:1063–1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7972318</ArticleId><ArticleId IdType="pubmed">33676597</ArticleId></ArticleIdList></Reference><Reference><Citation>Reche PA. Potential cross-reactive immunity to SARS-CoV-2 from common human pathogens and vaccines. Front Immunol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596387</ArticleId><ArticleId IdType="pubmed">33178220</ArticleId></ArticleIdList></Reference><Reference><Citation>R: The R project for statistical computing. 2021. Available at: https://www.r-project.org/. Accessed October 7, 2021.</Citation></Reference><Reference><Citation>Row Splitter. KNIME Hub. 2021. Available at: https://hub.knime.com/knime/extensions/org.knime.features.base/latest/org.knime.base.node.preproc.filter.row.RowFilter2PortNodeFactory. Accessed October 7, 2021.</Citation></Reference><Reference><Citation>Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A, et al. Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses. 2020;63:771–778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361944</ArticleId><ArticleId IdType="pubmed">32609906</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol. 2005;129:569–582. doi: 10.1111/j.1365-2141.2005.05397.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2005.05397.x</ArticleId><ArticleId IdType="pubmed">15916679</ArticleId></ArticleIdList></Reference><Reference><Citation>String Manipulation. KNIME Hub. 2021. Available at: https://hub.knime.com/knime/extensions/org.knime.features.javasnippet/latest/org.knime.base.node.preproc.stringmanipulation.StringManipulationNodeFactory. Accessed October 7, 2021.</Citation></Reference><Reference><Citation>Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363–374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso FY, Lidenge SJ, Peña PB, Clegg AA, Ngowi JR, Mwaiselage J, et al. High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa. Int J Infect Dis. 2021;102:577–583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648883</ArticleId><ArticleId IdType="pubmed">33176202</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner RB. The common cold. Mand Douglas Bennetts Princ Pract Infect Dis. 2015;1:748–752. e2.</Citation></Reference><Reference><Citation>Wickham H. The split-apply-combine strategy for data analysis. J Stat Softw. 2011;40:1–29.</Citation></Reference><Reference><Citation>Wickham H, François R, Henry L, Müller K. RStudio. dplyr: a grammar of data manipulation. (2021).</Citation></Reference><Reference><Citation>Zeng Q, Langereis MA, van Vliet ALW, Huizinga EG, de Groot RJ. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc Natl Acad Sci U S A. 2008;105:9065–9069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2449365</ArticleId><ArticleId IdType="pubmed">18550812</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741.</Citation><ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Perlman S. Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host. Curr Opin Virol. 2018;28:43–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5835172</ArticleId><ArticleId IdType="pubmed">29172107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213959</ArticleId><ArticleId IdType="pubmed">32408156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>